Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false question first answered
creator	label
publisher	pref label
tabling member	label

Search

1134907

	human indexable
	published
	registered interest
	answer date	01/07/2019
	date	26/06/2019
	date tabled	26/06/2019
	ddp created	26/06/2019 19:29:08
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	26/06/2019 19:38:58 05/07/2019 12:12:01
	hansard heading	100,000 Genomes Project
	house id	1
	identifier	269788
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/07/2019 11:40:47
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to evaluate the 100,000 Genomes Project.
	session	2017/19
	session number	1
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	title	House of Commons Tabled Parliamentary Question 2017/19 269788
	type	WrittenParliamentaryQuestion
	uin	269788
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 05/07/2019 11:40:47
	creator	4370 label Biography information for Jess Phillips
	publisher	25259 pref label House of Commons
	tabling member	4370 label Biography information for Jess Phillips

1077183

	human indexable
	published
	registered interest
	answer date	27/02/2019
	date	25/02/2019
	date tabled	25/02/2019
	ddp created	25/02/2019 22:56:42
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	25/02/2019 23:07:28 06/03/2019 17:13:03
	hansard heading	22q11.2 Deletion Syndrome
	house id	1
	identifier	225599
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	06/03/2019 16:41:39
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect on the public purse of adding a test for 22q11 deletion syndrome to the newborn blood spot test.
	session	2017/19
	session number	1
	tabling member constituency	Banff and Buchan
	tabling member printed	David Duguid
	title	House of Commons Tabled Parliamentary Question 2017/19 225599
	type	WrittenParliamentaryQuestion
	uin	225599
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 06/03/2019 16:41:39
	creator	4606 label Biography information for David Duguid
	publisher	25259 pref label House of Commons
	tabling member	4606 label Biography information for David Duguid

1077184

	human indexable
	published
	registered interest
	answer date	27/02/2019
	date	25/02/2019
	date tabled	25/02/2019
	ddp created	25/02/2019 22:56:44
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	25/02/2019 23:07:30 06/03/2019 17:13:02
	hansard heading	22q11.2 Deletion Syndrome
	house id	1
	identifier	225600
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	06/03/2019 16:41:39
	question text	To ask the Secretary of State for Health and Social Care, what his Department’s policy is on adding a test for 22q11 deletion syndrome to the newborn blood spot test.
	session	2017/19
	session number	1
	tabling member constituency	Banff and Buchan
	tabling member printed	David Duguid
	title	House of Commons Tabled Parliamentary Question 2017/19 225600
	type	WrittenParliamentaryQuestion
	uin	225600
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 06/03/2019 16:41:39
	creator	4606 label Biography information for David Duguid
	publisher	25259 pref label House of Commons
	tabling member	4606 label Biography information for David Duguid

908944

	human indexable
	published
	registered interest
	answer date	23/05/2018
	date	21/05/2018
	date tabled	21/05/2018
	ddp created	21/05/2018 21:46:04
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2018 21:55:37 23/05/2018 15:56:02
	hansard heading	5-aminolevulinic Acid
	house id	1
	identifier	146227
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	23/05/2018 15:24:50
	question text	To ask the Secretary of State for Health and Social Care, with reference to his Department's press release of 14 May 2018 entitled Government announces £40 million for brain cancer research in honour of Tessa Jowell, what the planned timetable is for the roll-out of 5-AminoLevulinic Acid to all brain cancer centres in England.
	session	2017/19
	session number	1
	tabling member constituency	Wigan
	tabling member printed	Lisa Nandy
	title	House of Commons Tabled Parliamentary Question 2017/19 146227
	type	WrittenParliamentaryQuestion
	uin	146227
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 23/05/2018 15:24:50
	creator	4082 label Biography information for Lisa Nandy
	publisher	25259 pref label House of Commons
	tabling member	4082 label Biography information for Lisa Nandy

1127892

	human indexable
	published
	registered interest
	answer date	23/05/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:45:27
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/05/2019 09:05:22 29/05/2019 11:06:04
	hansard heading	5G
	house id	1
	identifier	256910
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	29/05/2019 10:34:59
	question text	To ask the Secretary of State for Health and Social Care, what (a) health-and-safety research and (b) risk assessments his Department has (i) undertaken and (ii) commissioned on 5G technology.
	session	2017/19
	session number	1
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	title	House of Commons Tabled Parliamentary Question 2017/19 256910
	type	WrittenParliamentaryQuestion
	uin	256910
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 29/05/2019 10:34:59
	creator	252 label Biography information for Dr David Drew
	publisher	25259 pref label House of Commons
	tabling member	252 label Biography information for Dr David Drew

1127894

	human indexable
	published
	registered interest
	answer date	23/05/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:45:31
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/05/2019 09:05:24 29/05/2019 11:06:03
	hansard heading	5G
	house id	1
	identifier	256911
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	29/05/2019 10:34:59
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has (a) undertaken and (b) commissioned a regulatory safety testing on 5G radiofrequency radiation.
	session	2017/19
	session number	1
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	title	House of Commons Tabled Parliamentary Question 2017/19 256911
	type	WrittenParliamentaryQuestion
	uin	256911
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 29/05/2019 10:34:59
	creator	252 label Biography information for Dr David Drew
	publisher	25259 pref label House of Commons
	tabling member	252 label Biography information for Dr David Drew

1127896

	human indexable
	published
	registered interest
	answer date	23/05/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:45:36
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/05/2019 09:05:27 29/05/2019 11:06:01
	hansard heading	5G
	house id	1
	identifier	256912
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	29/05/2019 10:34:59
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to undertake (a) health-and-safety research and (b) a risk assessments before 5G is adopted in a localised test area.
	session	2017/19
	session number	1
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	title	House of Commons Tabled Parliamentary Question 2017/19 256912
	type	WrittenParliamentaryQuestion
	uin	256912
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 29/05/2019 10:34:59
	creator	252 label Biography information for Dr David Drew
	publisher	25259 pref label House of Commons
	tabling member	252 label Biography information for Dr David Drew

1091369

	human indexable
	published
	registered interest
	answer date	21/03/2019
	date	19/03/2019
	date tabled	19/03/2019
	ddp created	19/03/2019 19:53:09
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	19/03/2019 20:00:41 27/03/2019 16:14:02
	hansard heading	5G: Health Hazards
	house id	1
	identifier	234268
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	27/03/2019 15:42:52
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the roll-out of 5G technology on people's health.
	session	2017/19
	session number	1
	tabling member constituency	Cheltenham
	tabling member printed	Alex Chalk
	title	House of Commons Tabled Parliamentary Question 2017/19 234268
	type	WrittenParliamentaryQuestion
	uin	234268
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 27/03/2019 15:42:52
	creator	4481 label Biography information for Alex Chalk
	publisher	25259 pref label House of Commons
	tabling member	4481 label Biography information for Alex Chalk

1127949

	human indexable
	published
	registered interest
	answer date	23/05/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:47:57
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 18:02:10 30/05/2019 11:11:01
	hansard heading	5G: Health Hazards
	house id	1
	identifier	256920
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	30/05/2019 10:39:58
	question text	To ask the Secretary of State for Health and Social Care, what studies have been carried out to evaluate the effect of 5G on (a) pregnant women, (b) babies and (c) young children.
	session	2017/19
	session number	1
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	title	House of Commons Tabled Parliamentary Question 2017/19 256920
	type	WrittenParliamentaryQuestion
	uin	256920
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 30/05/2019 10:39:58
	creator	252 label Biography information for Dr David Drew
	publisher	25259 pref label House of Commons
	tabling member	252 label Biography information for Dr David Drew

1128914

	human indexable
	published
	registered interest
	answer date	05/06/2019
	date	03/06/2019
	date tabled	03/06/2019
	ddp created	03/06/2019 16:28:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	04/06/2019 18:15:04 11/06/2019 16:51:01
	hansard heading	5G: Health Hazards
	house id	1
	identifier	258952
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/06/2019 16:19:34
	question text	To ask the Secretary of State for Health and Social Care, what investigations the Government has commissioned on the health and safety implications of the 5G rollout.
	session	2017/19
	session number	1
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	title	House of Commons Tabled Parliamentary Question 2017/19 258952
	type	WrittenParliamentaryQuestion
	uin	258952
	version	3
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 11/06/2019 16:19:34
	creator	252 label Biography information for Dr David Drew
	publisher	25259 pref label House of Commons
	tabling member	252 label Biography information for Dr David Drew